Microsaic is the first, and only company to have successfully miniaturised mass spectrometry through the development of its patented chip-based technologies based on Micro-Electrical-Mechanical Systems (MEMS). This chip-based mass spectrometry technology enables point-of-need detection at any stage in a user’s workflow and allows pharmaceutical and biopharmaceutical industries to achieve processing and manufacturing agility, as well as commercial productivity.